Skip to content
Disclosery

Alphabet Inc.

Follow

13F filer, CIK 1652044, Mountain View, CA

Alphabet Inc. reported $2,579,790,897 across 29 holdings for the quarter ended 2025-12-31, in a 13F-HR filed 2026-02-13. Its ten largest share positions make up 92.81% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001652044-26-000023

Period
2025-12-31
Reported value
$2.58B
Holdings
29
Top 10 weight
92.81%
New
0
Sold out
8

Part of the filer group Alphabet Inc.

How groups are built

Stakes and trades reported after 2025-12-31

13D, 13G and Form 4 filings by this filer's group, dated after the 13F period, on securities the quarter does not hold as shares.

  • WULF TERAWULF INC: 13G 41,011,803 shares, 7.6% of the class, 13G filed 2026-09-25, 0001193125-26-402852Timeline
    Accepted , ingested

Largest buys vs the previous quarter

None.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
MTSRexited-3,783,528-$198M
RVMDreduced-788,175-$62.8M
MAZEreduced-1,023,888-$42.4M
GLUEreduced-719,067-$11.3M
DNTHexited-208,697-$8.21M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2025

Share positions as resolved from 13F-HR 0001652044-26-000023, largest first. % of portfolio is the value over $2,579,790,897, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
ASTSAST SPACEMOBILE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 8,943,486 shares; 2025Q2: 8,943,486 shares; 2025Q3: 8,943,486 shares; 2025Q4: 8,943,486 shares 8,943,486$650M25.18%0Timeline
PLPLANET LABS PBCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 31,942,641 shares; 2024Q4: 31,942,641 shares; 2025Q1: 31,942,641 shares; 2025Q2: 31,942,641 shares; 2025Q3: 31,942,641 shares; 2025Q4: 31,942,641 shares 31,942,641$630M24.42%0Timeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 4,256,175 shares; 2024Q4: 4,133,277 shares; 2025Q1: 4,133,277 shares; 2025Q2: 4,133,277 shares; 2025Q3: 4,133,277 shares; 2025Q4: 3,345,102 shares 3,345,102$266M10.33%-788,175Timeline
ARMARM HOLDINGS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,960,784 shares; 2024Q4: 1,960,784 shares; 2025Q1: 1,960,784 shares; 2025Q2: 1,960,784 shares; 2025Q3: 1,960,784 shares; 2025Q4: 1,960,784 shares 1,960,784$214M8.31%0Timeline
FRSHFRESHWORKS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 16,206,643 shares; 2024Q4: 16,206,643 shares; 2025Q1: 16,206,643 shares; 2025Q2: 16,206,643 shares; 2025Q3: 16,206,643 shares; 2025Q4: 16,206,643 shares 16,206,643$199M7.7%0Timeline
PATHUIPATH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 7,034,337 shares; 2024Q4: 7,034,337 shares; 2025Q1: 7,034,337 shares; 2025Q2: 7,034,337 shares; 2025Q3: 7,034,337 shares; 2025Q4: 7,034,337 shares 7,034,337$115M4.47%0Timeline
GTLBGITLAB INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 9,758,333 shares; 2024Q4: 6,091,238 shares; 2025Q1: 2,724,712 shares; 2025Q2: 2,724,712 shares; 2025Q3: 2,724,712 shares; 2025Q4: 2,724,712 shares 2,724,712$102M3.96%0Timeline
TEMTEMPUS AI INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,551,102 shares; 2024Q4: 1,551,102 shares; 2025Q1: 1,551,102 shares; 2025Q2: 1,551,102 shares; 2025Q3: 1,551,102 shares; 2025Q4: 1,551,102 shares 1,551,102$91.6M3.55%0Timeline
DXCMDEXCOM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,036,937 shares; 2024Q4: 1,036,937 shares; 2025Q1: 1,036,937 shares; 2025Q2: 1,036,937 shares; 2025Q3: 1,036,937 shares; 2025Q4: 1,036,937 shares 1,036,937$68.8M2.67%0Timeline
MAZEMAZE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 2,412,471 shares; 2025Q2: 2,412,471 shares; 2025Q3: 2,412,471 shares; 2025Q4: 1,388,583 shares 1,388,583$57.5M2.23%-1,023,888Timeline
PRMEPRIME MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 15,062,498 shares; 2024Q4: 15,062,498 shares; 2025Q1: 15,062,498 shares; 2025Q2: 15,062,498 shares; 2025Q3: 16,562,498 shares; 2025Q4: 16,562,498 shares 16,562,498$57.5M2.23%0Timeline
BBOTBRIDGEBIO ONCOLOGY THERAPEUTQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 2,823,126 shares; 2025Q4: 2,823,126 shares 2,823,126$35.3M1.37%0Timeline
RLAYRELAY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,568,753 shares; 2024Q4: 1,568,753 shares; 2025Q1: 1,568,753 shares; 2025Q2: 1,568,753 shares; 2025Q3: 1,568,753 shares; 2025Q4: 1,568,753 shares 1,568,753$13.3M0.51%0Timeline
VERAVERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 241,264 shares; 2024Q4: 241,264 shares; 2025Q1: 241,264 shares; 2025Q2: 241,264 shares; 2025Q3: 241,264 shares; 2025Q4: 241,264 shares 241,264$12.2M0.47%0Timeline
GLUEMONTE ROSA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,464,015 shares; 2024Q4: 1,464,015 shares; 2025Q1: 1,464,015 shares; 2025Q2: 1,464,015 shares; 2025Q3: 1,464,015 shares; 2025Q4: 744,948 shares 744,948$11.7M0.45%-719,067Timeline
SANASANA BIOTECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,812,500 shares; 2024Q4: 2,812,500 shares; 2025Q1: 2,812,500 shares; 2025Q2: 2,812,500 shares; 2025Q3: 2,812,500 shares; 2025Q4: 2,812,500 shares 2,812,500$11.4M0.44%0Timeline
LYELLYELL IMMUNOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 293,256 shares; 2025Q3: 293,256 shares; 2025Q4: 293,256 shares 293,256$9.03M0.35%0Timeline
BEAMBEAM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 321,604 shares; 2024Q4: 321,604 shares; 2025Q1: 321,604 shares; 2025Q2: 321,604 shares; 2025Q3: 321,604 shares; 2025Q4: 321,604 shares 321,604$8.91M0.35%0Timeline
FIGFIGMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 215,582 shares; 2025Q4: 215,582 shares 215,582$8.06M0.31%0Timeline
OSCROSCAR HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 481,988 shares; 2024Q4: 481,988 shares; 2025Q1: 481,988 shares; 2025Q2: 481,988 shares; 2025Q3: 481,988 shares; 2025Q4: 481,988 shares 481,988$6.93M0.27%0Timeline
WGSGENEDX HOLDINGS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 22,711 shares; 2024Q4: 22,711 shares; 2025Q1: 22,711 shares; 2025Q2: 22,711 shares; 2025Q3: 22,711 shares; 2025Q4: 22,711 shares 22,711$2.95M0.11%0Timeline
EXASEXACT SCIENCES CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 23,205 shares; 2024Q4: 23,205 shares; 2025Q1: 23,205 shares; 2025Q2: 23,205 shares; 2025Q3: 23,205 shares; 2025Q4: 23,205 shares 23,205$2.36M0.09%0Timeline
SPROSPERO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 889,979 shares; 2024Q4: 889,979 shares; 2025Q1: 889,979 shares; 2025Q2: 889,979 shares; 2025Q3: 889,979 shares; 2025Q4: 889,979 shares 889,979$2.07M0.08%0Timeline
AUTLAUTOLUS THERAPEUTICS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 698,262 shares; 2024Q4: 698,262 shares; 2025Q1: 698,262 shares; 2025Q2: 698,262 shares; 2025Q3: 698,262 shares; 2025Q4: 698,262 shares 698,262$1.39M0.05%0Timeline
HYPRHYPERFINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 898,720 shares; 2024Q4: 898,720 shares; 2025Q1: 898,720 shares; 2025Q2: 898,720 shares; 2025Q3: 898,720 shares; 2025Q4: 898,720 shares 898,720$881K0.03%0Timeline
TNYATENAYA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 915,705 shares; 2024Q4: 915,705 shares; 2025Q1: 915,705 shares; 2025Q2: 915,705 shares; 2025Q3: 915,705 shares; 2025Q4: 915,705 shares 915,705$650K0.03%0Timeline
QNCXQUINCE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 189,122 shares; 2024Q4: 189,122 shares; 2025Q1: 189,122 shares; 2025Q2: 189,122 shares; 2025Q3: 189,122 shares; 2025Q4: 189,122 shares 189,122$634K0.02%0Timeline
FULCFULCRUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 14,262 shares; 2024Q4: 14,262 shares; 2025Q1: 14,262 shares; 2025Q2: 14,262 shares; 2025Q3: 14,262 shares; 2025Q4: 14,262 shares 14,262$161K0.01%0Timeline
RGENREPLIGEN CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 383 shares; 2024Q4: 383 shares; 2025Q1: 383 shares; 2025Q2: 383 shares; 2025Q3: 383 shares; 2025Q4: 383 shares 383$62.8K<0.01%0Timeline

Sold out in Q4 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
MTSRMETSERA INC3,783,528$198Mshares
DNTHDIANTHUS THERAPEUTICS INC208,697$8.21Mshares
FHTXFOGHORN THERAPEUTICS INC500,901$2.45Mshares
TSHATAYSHA GENE THERAPIES INC640,882$2.1Mshares
TCRXTSCAN THERAPEUTICS INC1,077,080$1.96Mshares
BRNSBARINTHUS BIOTHERAPEUTICS PL1,513,644$1.89Mshares
GUTSFRACTYL HEALTH INC662,584$1.05Mshares
ALECALECTOR INC175,866$521Kshares

How Q4 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001652044-26-000023 base2026-02-13acceptance time not in the bulk data set